- 全部删除
 
您的购物车当前为空
NF-κB-IN-15 (compound 14r) 是一种高效的NF-κB抑制剂。它能够降低LPS诱导细胞中的NO水平,并抑制IL-6、TNF-α和IL-1β的释放。此外,NF-κB-IN-15 抑制LPS诱导的p65磷酸化和IκBα降解。此化合物显示出显著的抗炎活性,具有用于急性肺损伤 (ALI) 研究的潜在应用价值。
NF-κB-IN-15 (compound 14r) 是一种高效的NF-κB抑制剂。它能够降低LPS诱导细胞中的NO水平,并抑制IL-6、TNF-α和IL-1β的释放。此外,NF-κB-IN-15 抑制LPS诱导的p65磷酸化和IκBα降解。此化合物显示出显著的抗炎活性,具有用于急性肺损伤 (ALI) 研究的潜在应用价值。

NF-κB-IN-15 相关产品
| 产品描述 | NF-κB-IN-15 (compound 14r) is a potent NF-κB inhibitor. It reduces NO levels in LPS-stimulated cells and suppresses the release of IL-6, TNF-α, and IL-1β. Additionally, it hinders LPS-induced p65 phosphorylation and IκBα degradation. NF-κB-IN-15 exhibits anti-inflammatory properties and holds potential for research in acute lung injury (ALI).  | 
| 体外活性 | NF-κB-IN-15 (compound 14r) (1.25, 2.5, 5, 10, 20 µM; 1+24 h)在LPS诱导的RAW 264.7细胞中通过剂量依赖性降低NO水平,并抑制IL-6、TNF-α、IL-1β。NF-κB-IN-15(10、20 µM; 1+4 h)可抑制LPS诱导的p65磷酸化及IκBα降解。  | 
| 体内活性 | NF-κB-IN-15 (compound 14r) (20 mg/kg; i.p.) 在急性肺损伤 (ALI) 小鼠模型中展现出抗炎功效。  | 
| 分子式 | C46H58N4O8 | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容